BiotechTube
Home/Aldeyra Therapeutics/Stephen G. Machatha
SG

Stephen G. Machatha

Chief Development Officer

Aldeyra Therapeutics

Therapeutic Areas

OphthalmologyImmunology

Aldeyra Therapeutics Pipeline

DrugIndicationPhase
ReproxalapDry Eye DiseaseNDA Submitted
ADX-2191Primary Vitreoretinal LymphomaPhase 3
ADX-629Systemic Immune-Mediated DiseasesPhase 2a

Leadership Team at Aldeyra Therapeutics

TC
Todd C. Brady
President, CEO & Chairman
DJ
David J. Clark
Chief Medical Officer
JR
Joshua Reed
Chief Financial Officer & Treasurer
BH
Ben H. McGraw III
Chief Commercial Officer
View full Aldeyra Therapeutics profile